Tyche Wealth Partners LLC Has $6.50 Million Stock Position in Procter & Gamble Company (The) $PG

Tyche Wealth Partners LLC trimmed its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 0.2% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 40,777 shares of the company’s stock after selling 91 shares during the period. Procter & Gamble makes up approximately 1.3% of Tyche Wealth Partners LLC’s investment portfolio, making the stock its 17th largest position. Tyche Wealth Partners LLC’s holdings in Procter & Gamble were worth $6,497,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. RMG Wealth Management LLC acquired a new position in Procter & Gamble during the second quarter valued at $37,000. MADDEN SECURITIES Corp raised its position in Procter & Gamble by 4.6% during the second quarter. MADDEN SECURITIES Corp now owns 1,531 shares of the company’s stock valued at $244,000 after buying an additional 68 shares during the period. Seamount Financial Group Inc. raised its position in Procter & Gamble by 38.3% during the second quarter. Seamount Financial Group Inc. now owns 6,910 shares of the company’s stock valued at $1,101,000 after buying an additional 1,915 shares during the period. Bennett Associates Wealth Management acquired a new position in Procter & Gamble in the 2nd quarter worth about $226,000. Finally, Drake & Associates LLC acquired a new position in Procter & Gamble in the 2nd quarter worth about $417,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Trading Down 1.2%

Shares of PG opened at $150.47 on Tuesday. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The stock has a 50 day simple moving average of $155.38 and a 200-day simple moving average of $159.84. The stock has a market cap of $352.17 billion, a PE ratio of 23.11, a PEG ratio of 4.02 and a beta of 0.36.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The firm had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm posted $1.40 EPS. The business’s revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on PG shares. UBS Group set a $180.00 target price on Procter & Gamble and gave the stock a “buy” rating in a research report on Wednesday, July 30th. Evercore ISI reaffirmed an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research report on Friday, July 25th. Wells Fargo & Company dropped their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Finally, Berenberg Bank upped their target price on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research report on Wednesday, September 17th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $173.11.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares in the company, valued at approximately $4,409,221.72. This trade represents a 31.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of the stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares in the company, valued at $8,279,007.34. The trade was a 18.11% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.